| Literature DB >> 20503046 |
Berlinda J van der Veen1, Arthur J Scholte, Petra Dibbets-Schneider, Marcel P M Stokkel.
Abstract
PURPOSE: Semiquantitative analysis of myocardial perfusion scintigraphy (MPS) has reduced inter- and intraobserver variability, and enables researchers to compare parameters in the same patient over time, or between groups of patients. There are several software packages available that are designed to process MPS data and quantify parameters. In this study the performances of two systems, quantitative gated SPECT (QGS) and 4D-MSPECT, in the processing of clinical patient data and phantom data were compared.Entities:
Mesh:
Year: 2010 PMID: 20503046 PMCID: PMC2918795 DOI: 10.1007/s00259-010-1465-6
Source DB: PubMed Journal: Eur J Nucl Med Mol Imaging ISSN: 1619-7070 Impact factor: 9.236
Fig. 1AGATE heart phantom with twin membrane lumen representing the myocardial wall and LV lumen placed in a water-filled Plexiglas torso. The LV volume is adjusted by a computer-controlled pumping system to produce different LVEF values
Patient characteristics
| Characteristic | Value | |
|---|---|---|
| Risk factors | Age (years) | 60.6 ± 10.2 |
| BMI (kg/m2) | 27.6 ± 4.4 | |
| Male gender, | 105 (70.9) | |
| Smoker, | 57 (38.5) | |
| Alcohol abuser, | 14 (9.5) | |
| Hypercholesterolaemia, | 57 (38.5) | |
| Hypertension, | 81 (54.7) | |
| Positive family history, | 50 (33.7) | |
| Diabetic, | 33 (22.2) | |
| History of CAD or infarction, | 83 (56.1) | |
| Medication | β-Blocker, | 107 (72.3) |
| Calcium antagonist, | 13 (8.8) | |
| ACE inhibitor, | 67 (45.2) | |
| Reason for MPS | Chest pain, | 24 (16.2) |
| Proven/suspected CAD or infarction, | 85 (57.4) | |
| Abnormal ECG or stress test, | 15 (10.1) | |
| Stem cell protocol, | 10 (6.7) | |
| Preoperative screening, | 7 (4.7) | |
| Other, | 7 (4.7) | |
| MPS results | Exercise as stressor, | 77 (52.0) |
| Normal scan, | 31 (20.9) | |
| Average rest ESV (ml) | 72.0 ± 65.7 | |
| Average rest EDV (ml) | 138.2 ± 71.7 | |
| Average rest LVEF (%) | 54.6 ± 15.9 |
EDV, ESV and LVEF calculated by 4D-MSPECT and QGS
| Rest acquisitions | Poststress acquisitions | |||||
|---|---|---|---|---|---|---|
| Mean | Difference |
| Mean | Difference |
| |
| EDV (ml) | ||||||
| QGS | 124.6 ± 66.2 | 27.3 ± 19.5 | <0.001* | 122.1 ± 66.8 | 27.2 ± 21.3 | <0.001* |
| 4D-MSPECT | 151.9 ± 78.0 | 149.3 ± 82.0 | ||||
| ESV (ml) | ||||||
| QGS | 67.7 ± 61.0 | 8.8 ± 19.1 | <0.001* | 65.6 ± 62.2 | 8.5 ± 19.1 | <0.001* |
| 4D-MSPECT | 76.4 ± 71.3 | 74.1 ± 75.5 | ||||
| LVEF (%) | ||||||
| QGS | 52.6 ± 16.0 | 4.0 ± 7.9 | <0.001* | 54.0 ± 17.5 | 4.3 ± 7.4 | <0.001* |
| 4D-MSPECT | 56.6 ± 16.7 | 58.3 ± 17.6 | ||||
*p < 0.05, paired Student’s t-test.
Fig. 2Bland-Altman analyses of EDV, ESV and LVEF calculated by the two software systems for the rest and poststress acquisitions. Bland-Altman analysis indicates the difference of the estimates obtained by the two systems (4D-MSPECT − QGS) in relation to the average of these estimates. The red dashed lines represent the Bland-Altman limits (±1.96×SD), the red solid lines represent the mean differences, and the blue dashed lines are the lines of equality
Influence of various factors on differences in EDV, ESV and LVEF determined by QGS and 4D-MSPECT (means±SD)
| Factor | Acquisition | Difference in EDV (ml) | Difference in ESV (ml) | Difference in LVEF (%) | ||||
|---|---|---|---|---|---|---|---|---|
| Mean |
| Mean |
| Mean |
| |||
| Gender | Male | Rest | 28.8 ± 21.0 | <0.001 | 9.6 ± 20.7 | <0.001 | 4.6 ± 7.2 | <0.001 |
| Female | Rest | 23.9 ± 15.1 | <0.001 | 6.8 ± 14.5 | 0.003 | 2.5 ± 9.2 | 0.073a | |
| Male | Stress | 29.3 ± 23.5 | <0.001 | 9.9 ± 20.7 | <0.001 | 4.7 ± 6.5 | <0.001 | |
| Female | Stress | 22.2 ± 13.7 | <0.001 | 5.3 ± 14.5 | 0.020 | 3.3 ± 9.2 | 0.022 | |
| Defect type | Normal | Rest | 19.5 ± 10.4 | <0.001 | 2.0 ± 8.7 | 0.216a | 3.2 ± 11.0 | 0.116a |
| Reversible | Rest | 22.8 ± 10.4 | <0.001 | 3.7 ± 6.9 | 0.059a | 4.4 ± 7.1 | 0.032 | |
| Persistent | Rest | 31.4 ± 24.6 | <0.001 | 13.4 ± 24.7 | <0.001 | 3.6 ± 6.7 | <0.001 | |
| Combination | Rest | 28.7 ± 16.6 | <0.001 | 8.6 ± 15.8 | 0.002 | 5.2 ± 6.9 | <0.001 | |
| Normal | Stress | 17.9 ± 11.1 | <0.001 | 0.8 ± 9.3 | 0.633a | 4.1 ± 9.5 | 0.024 | |
| Reversible | Stress | 22.8 ± 8.8 | <0.001 | 2.5 ± 8.6 | 0.272a | 5.5 ± 7.2 | 0.010 | |
| Persistent | Stress | 31.5 ± 28.1 | <0.001 | 13.5 ± 24.2 | <0.001 | 3.7 ± 6.7 | <0.001 | |
| Combination | Stress | 29.2 ± 14.8 | <0.001 | 8.8 ± 16.0 | 0.001 | 5.0 ± 6.7 | <0.001 | |
| Stressor type | Adenosine | Rest | 29.1 ± 14.8 | <0.001 | 8.8 ± 20.9 | <0.001 | 4.9 ± 8.8 | <0.001 |
| Exercise | Rest | 25.4 ± 16.4 | <0.001 | 8.7 ± 16.9 | <0.001 | 3.1 ± 6.7 | <0.001 | |
| Adenosine | Stress | 30.4 ± 25.5 | <0.001 | 10.6 ± 22.8 | <0.001 | 4.8 ± 8.8 | <0.001 | |
| Exercise | Stress | 23.8 ± 14.8 | <0.001 | 6.2 ± 13.8 | <0.001 | 3.7 ± 6.2 | <0.001 | |
| Heart size (EDV, ml) | ≤70 | Rest | 15.1 ± 5.3 | <0.001 | 3.1 ± 4.6 | 0.005 | −1.2 ± 10.3 | 0.647a |
| >70 | Rest | 28.7 ± 19.9 | <0.001 | 9.3 ± 20.0 | <0.001 | 4.6 ± 7.4 | <0.001 | |
| ≤70 | Stress | 14.5 ± 5.4 | <0.001 | 3.1 ± 4.6 | 0.020 | −0.2 ± 7.7 | 0.901a | |
| >70 | Stress | 28.6 ± 22.0 | <0.001 | 9.1 ± 20.0 | <0.001 | 4.8 ± 7.2 | <0.001 | |
| BMI (kg/m2) | <30 | Rest | 24.6 ± 17.3 | <0.001 | 6.8 ± 18.2 | <0.001 | 4.7 ± 8.4 | <0.001 |
| ≥30 | Rest | 33.9 ± 23.0 | <0.001 | 13.6 ± 20.4 | <0.001 | 2.3 ± 6.2 | 0.013 | |
| <30 | Stress | 26.2 ± 23.3 | <0.001 | 7.5 ± 20.7 | <0.001 | 5.1 ± 7.8 | <0.001 | |
| ≥30 | Stress | 29.7 ± 15.3 | <0.001 | 11.0 ± 14.3 | <0.001 | 2.3 ± 5.8 | 0.017 | |
Paired Student’s t-test was used to determine the significance of the differences (p values) between the 4D-MSPECT and QGS estimates.
aNonsignificant difference (p > 0.05).
Fig. 3Linear relationship between the phantom data and QGS estimates (triangles, solid line) and between the phantom data and the 4D-MSPECT estimates (circles, dashed line). The dotted line is the line of equality representing complete agreement between the phantom data and the software package estimates